U.S. markets open in 56 minutes
  • S&P Futures

    4,397.25
    -5.75 (-0.13%)
     
  • Dow Futures

    34,890.00
    -61.00 (-0.17%)
     
  • Nasdaq Futures

    15,081.00
    -17.00 (-0.11%)
     
  • Russell 2000 Futures

    2,210.20
    +5.10 (+0.23%)
     
  • Crude Oil

    72.00
    -0.07 (-0.10%)
     
  • Gold

    1,805.40
    +3.60 (+0.20%)
     
  • Silver

    25.35
    +0.12 (+0.46%)
     
  • EUR/USD

    1.1792
    +0.0022 (+0.19%)
     
  • 10-Yr Bond

    1.2860
    0.0000 (0.00%)
     
  • Vix

    18.34
    +0.65 (+3.67%)
     
  • GBP/USD

    1.3781
    +0.0027 (+0.20%)
     
  • USD/JPY

    110.3400
    -0.1700 (-0.15%)
     
  • BTC-USD

    38,801.91
    +4,405.53 (+12.81%)
     
  • CMC Crypto 200

    929.50
    +135.76 (+17.10%)
     
  • FTSE 100

    7,025.41
    -2.17 (-0.03%)
     
  • Nikkei 225

    27,833.29
    +285.29 (+1.04%)
     

Is Pfizer Stock Undervalued?

·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Pfizer's (NYSE: PFE) revenue and earnings are skyrocketing, thanks in large part to the success of its COVID-19 vaccine. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question asking if Pfizer stock is undervalued right now. Keith Speights: One at the top that's got the most upvotes is from Richard.